Pain and Chemical Dependency Not an “Either – Or” proposition Douglas Gourlay, MD, FRCPC, FASAM Wasser Pain Centre, Toronto ON.
Family Education Session 1: Triggers and Cravings 1-1.
Family Education 1-1 Session 1: Triggers and Cravings.
Melanie M. Watkins, MD Staff Psychiatrist Contra Costa Regional Medical Center December 15, 2010 Melanie Watkins, MD.
Buprenorphine in the treatment of addiction Matthew A. Torrington MD Clinical Research Physician UCLA: Integrated Substance Abuse Programs Matrix Institute.
Outline Definitions Case study “elizabeth” Chronic vs. palliative symptoms Pain Other symptoms Case study “John” Case study “LM”(maybe if time) Pump discussion.
PowerPoint
Diagnosis and Treatment of Opioid Dependence Matthew A. Torrington, MD AAFP ASAM Medical Director, Matrix Institute Narcotic Treatment Program Clinical.
Addiction is a primary, chronic, neurobiologic disease with genetic, psychosocial, and environmental factors influencing its development and manifestations.
Pain Assessment Subjective Data Comprehensive pain history includes COLDERR – Character – Onset – Location – Duration – Exacerbation – Relief – Radiation.
1 Ensuring Proper Use and Curbing Abuse of Opioids: An Industry Perspective J. David Haddox, DDS, MD Senior Medical Director, Health Policy Purdue Pharma.
Sobriety
